Hubungan CXC Chemokine Receptor 4 (CXCR4) dan Matrix Metalloproteinase 9 (MMP 9) dengan Kemampuan Metastasis Adenokarsinoma Prostat
Authors
-
Sri Murtiyani
-
Bethy S. Hernowo
-
Sri Suryanti
Keywords:
Adenokarsinoma prostat, CXCR4, metastasis, MMP 9, non metastasisAbstract
Karsinoma prostat merupakan keganasan kedua terbanyak pada laki-laki dan merupakan penyebab kematian kelima diseluruh dunia. Faktor prognosis utama pada adenokarsinoma prostat adalah metastasis yang menyebabkan tingginya angka kematian. Keadaan ini disebabkan karena pada kasus adenokarsinoma prostat yang metastasis pilihan terapi belum mendapatkan hasil yang memuaskan karena terdapat faktor resisten terhadap terapi radiasi dan kemoterapi. CXCR4 dan MMP 9 merupakan petanda imunohistokimia yang berfungsi dalam proses migrasi, chemotaxis dan detachment yang memegang peranan terhadap terjadinya metastasis pada adenokarsinoma prostat. Tujuan penelitian ini adalah mencari hubungan imunoekspresi CXCR4 dan MMP 9 dengan metastasis pada adenokarsinoma prostat.
Penelitian ini menggunakan desain potong lintang dan observasional analitik. Sampel diambil dari blok parafin yang tersedia di Departemen Patologi Anatomi RSUP Dr. Hasan Sadikin Bandung pada periode 2010-2016. Jumlah sampel sebanyak 52 sampel, dibagi menjadi 2 kelompok, yaitu kelompok metastasis 26 sampel dan kelompok non metastasis 26 sampel. Keseluruhan sampel dilakukan pulasan imunohistokimia CXCR4 dan MMP 9.
Hasil penelitian ini menunjukkan bahwa 71% sampel mengekspresikan CXCR4 kuat dengan proporsi terbesar pada kelompok metastasis (nilai p=0,000) dan 56% sampel mengekspresikan MMP 9 lemah pada kelompok metastasis (nilai p=0,55).
CXCR4 dapat digunakan sebagai faktor prediksi metastasis pada adenokarsinoma prostat.References
Anandia Putriyuni NH 2014. Adenokarsinoma Prostat : Penilaian Prognostik Dan Derajat Histopatologi. Jurnal Mka-Fk.Unand, 37, 93-100.
Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R, Beider K, Avniel S, Kasem S, Galun E & Peled A 2004. Role Of High Expression Levels Of Cxcr4 In Tumor Growth, Vascularization, And Metastasis. Faseb J, 18, 1240-2.
Domanska UM, Kruizinga RC, Nagengast WB, Timmer-Bosscha H, Huls G, De Vries EGE & Walenkamp AME 2013. A Review On Cxcr4/Cxcl12 Axis In Oncology: No Place To Hide. European Journal Of Cancer, 49, 219-230.
Elsa Yullus IP, Anna Tjandrawati, Dewi Kartika 2014. Keabsahan Engrailed-2 Di Kanker Prostat Indonesian Journal Of Clinical Pathology And Medical Laboratory, 20, 150-153.
Felgueiras J, Silva JV & Fardilha M 2014. Prostate Cancer: The Need For Biomarkers And New Therapeutic Targets. Journal Of Zhejiang University. Science. B, 15, 16-42.
Holger Moch PAH, Thomas M Ulbright, Victor E Reuter 2016. Tumours Of The Prostate. Who Classification Of Tumours Of The Urinary System And Male Genital Organs. Fourth Ed. Switzerland: International Agency For Research On Cancer (Iarc) Lyon.
Jung SJ, Kim CI, Park CH, Chang HS, Kim BH, Choi MS & Jung HR 2011. Correlation Between Chemokine Receptor Cxcr4 Expression And Prognostic Factors In Patients With Prostate Cancer. Korean Journal Of Urology, 52, 607-611.
Kingsley LA, Fournier PG, Chirgwin JM & Guise TA 2007. Molecular Biology Of Bone Metastasis. Mol Cancer Ther, 6, 2609-17.
Koskensalo S, Hagström J, Linder N, Lundin M, Sorsa T, Louhimo J & Haglund C 2012. Lack Of Mmp-9 Expression Is A Marker For Poor Prognosis In Dukes’ B Colorectal Cancer. Bmc Clinical Pathology, 12, 24.
Lee JY, Kang DH, Chung DY, Kwon JK, Lee H, Cho NH, Choi YD, Hong SJ & Cho KS 2014. Meta-Analysis Of The Relationship Between Cxcr4 Expression And Metastasis In Prostate Cancer. The World Journal Of Men's Health, 32, 167-175.
Liu CF, Liu SY, Min XY, Ji YY, Wang N, Liu D, Ma N, Li ZF & Li K 2014. The Prognostic Value Of Cxcr4 In Ovarian Cancer: A Meta-Analysis. Plos One, 9, E92629.
Luker KE & Luker GD 2006. Functions Of Cxcl12 And Cxcr4 In Breast Cancer. Cancer Letters, 238, 30-41.
Mehmet Topqul EC 2014. The Biology Of Cancer Metastasis. 1-20.
Merdad A, Karim S, Schulten HJ, Dallol A, Buhmeida A, Al-Thubaity F, Gari MA, Chaudhary AG, Abuzenadah AM & Al-Qahtani MH 2014. Expression Of Matrix Metalloproteinases (Mmps) In Primary Human Breast Cancer: Mmp-9 As A Potential Biomarker For Cancer Invasion And Metastasis. Anticancer Res, 34, 1355-66.
Mohamed MA & Abdel-Aziz A 2011. Evaluation Of Cxcr4 Chemokine Receptor As A Prognostic Marker In Colorectal Carcinoma. Egyptian Journal Of Pathology, 31, 19-24.
Sun YX, Schneider A, Jung Y, Wang J, Dai J, Wang J, Cook K, Osman NI, Koh-Paige AJ, Shim H, Pienta KJ, Keller ET, Mccauley LK & Taichman RS 2005. Skeletal Localization And Neutralization Of The Sdf-1(Cxcl12)/Cxcr4 Axis Blocks Prostate Cancer Metastasis And Growth In Osseous Sites In Vivo. Journal Of Bone And Mineral Research, 20, 318-329.
Valdo R.Solang AM 2016. Profil Penderita Kanker Prostat Di Rsup Prof.Dr.R.D.Kandou Manado Periode Tahun 2013-2015. Jurnal E-Clinic, 4, 93-8.
Weiner AB, Matulewicz RS, Eggener SE & Schaeffer EM 2016. Increasing Incidence Of Metastatic Prostate Cancer In The United States (2004-2013). Prostate Cancer Prostatic Dis, 19, 395-397.
Wu QW, Yang QM, Huang YF, She HQ, Liang J, Yang QL & Zhang ZM 2014. Expression And Clinical Significance Of Matrix Metalloproteinase-9 In Lymphatic Invasiveness And Metastasis Of Breast Cancer. Plos One, 9, E97804.
Xin Wei Diao JYF, Qin Wen Wang, Jian Guo Sun 2015. Sdf-1/Cxcr4 Axis Promotes Prostate Cancer Cell Invasion And Bone Metastasis Through P38, Nf-Kb And Hif-1pathways. Int J Clin Exp Pathol, 2706-17.
Zhao H, Guo L, Zhao H, Zhao J, Weng H & Zhao B 2015. Cxcr4 Over-Expression And Survival In Cancer: A System Review And Meta-Analysis. Oncotarget, 6, 5022-40.
Zhao S, Wang J & Qin C 2014. Blockade Of Cxcl12/Cxcr4 Signaling Inhibits Intrahepatic Cholangiocarcinoma Progression And Metastasis Via Inactivation Of Canonical Wnt Pathway. Journal Of Experimental & Clinical Cancer Research : Cr, 33, 103.
Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K & Takano Y 2006. Expressions Of Mmp-2, Mmp-9 And Vegf Are Closely Linked To Growth, Invasion, Metastasis And Angiogenesis Of Gastric Carcinoma. Anticancer Res, 26, 3579-83.
Zhu X, Bai Q, Lu Y, Lu Y, Zhu L, Zhou X & Wu L 2016. Expression And Function Of Cxcl12/Cxcr4/Cxcr7 In Thyroid Cancer. International Journal Of Oncology, 48, 2321-2329.
